Prescription stimulants are primarily used to treat ADHD, narcolepsy, and binge eating disorder. These are the three FDA-approved uses, though stimulants are also prescribed off-label for a handful of other conditions. All prescription stimulants work by increasing levels of two chemical messengers in the brain: dopamine, which drives motivation and reward, and norepinephrine, which sharpens attention and alertness.
ADHD: The Most Common Use
Attention-deficit/hyperactivity disorder is by far the leading reason stimulants are prescribed. Clinical practice guidelines across most countries list stimulants as the first-line medication for ADHD in children, adolescents, and adults. The two main drug families are methylphenidate-based medications and amphetamine-based medications. Both block the recycling of dopamine and norepinephrine back into nerve cells, which keeps more of those chemicals active in the spaces between neurons. The practical result is better focus, less impulsivity, and improved working memory.
Stimulants have one of the highest response rates of any psychiatric medication. The landmark Multimodal Treatment of ADHD study found that symptoms improved in more than 70% of participants when methylphenidate was dosed across its full range. Studies in adults show similar numbers: response rates between 71% and 77% on stimulants compared to 23% to 44% on placebo. Roughly three out of four adults experienced at least a 50% reduction in symptom scores.
Stimulants for ADHD come in short-acting and long-acting formulations. Short-acting versions last about four hours, so they typically require multiple doses throughout the day. Most long-acting formulations provide about 12 hours of symptom control from a single morning dose, and one (lisdexamfetamine) lasts up to 14 hours. The choice between them usually depends on how much of the day you need coverage and how you tolerate the medication.
Narcolepsy and Excessive Daytime Sleepiness
Narcolepsy causes overwhelming daytime sleepiness that sleep alone can’t fix. Stimulants and other wakefulness-promoting agents are the main treatment for this symptom. The options span a range of potencies, and which one works best depends on how severe the sleepiness is.
For mild to moderate sleepiness, modafinil and armodafinil are common first choices. They aren’t traditional stimulants in the way amphetamines are, but they promote wakefulness through related pathways. Large clinical trials show they reduce feelings of sleepiness and moderately improve the ability to stay awake during objective testing. For more severe sleepiness, amphetamine-based medications are among the most effective options, though side effects are more common.
Two newer medications have expanded the toolkit. Solriamfetol, taken in the morning, substantially improves both subjective alertness and objective wakefulness across the day. Pitolisant works through a different mechanism and can improve sleepiness measures with effects lasting into the evening. Oxybates, taken at night, are a separate class: after several weeks of regular use they reduce daytime sleepiness and also help with cataplexy, the sudden muscle weakness that some people with narcolepsy experience.
Binge Eating Disorder
Lisdexamfetamine (sold as Vyvanse) is the only FDA-approved medication specifically for binge eating disorder. It’s the same drug used for ADHD, but in this context it reduces the compulsive drive to binge eat. The drug is a prodrug, meaning the body converts it into its active form (dextroamphetamine) after ingestion. This conversion process gives it a slower, smoother onset than traditional amphetamines.
The exact mechanism behind its effect on binge eating isn’t fully understood, but it increases dopamine and norepinephrine signaling, which appears to reduce appetite and improve impulse control around food. It does not have FDA approval for weight loss on its own, and it’s prescribed specifically for the behavioral pattern of binge eating rather than as a general appetite suppressant.
Off-Label Uses
Beyond the three approved indications, stimulants are sometimes prescribed off-label for other conditions. The most common off-label uses include treatment-resistant depression (particularly in older adults), recovery from traumatic brain injury, and, less commonly, obesity. The evidence supporting these uses is modest compared to the robust data behind ADHD and narcolepsy treatment. Amphetamine-related compounds like phentermine have a long history of use for weight loss, but this remains controversial and is generally not considered best practice for long-term management.
In depression, stimulants are typically added to an existing antidepressant regimen when standard treatments haven’t worked. They can provide a faster boost in energy and motivation, but the supporting research is limited and they aren’t part of standard depression treatment guidelines.
How Stimulants Affect the Heart
Because stimulants increase norepinephrine activity, they can raise heart rate and blood pressure. A large meta-analysis of over 2,600 adults found that stimulants increased resting heart rate by an average of about 6 beats per minute and systolic blood pressure by about 1.2 mmHg. For most healthy people, these changes are small and clinically insignificant. The overall risk of a serious cardiovascular event like dangerously high blood pressure or an abnormal heart rhythm was 5% or lower.
The risks are higher for people with pre-existing heart conditions. In children with congenital heart disease, the rate of abnormal heart rhythms increased notably during stimulant treatment. The FDA advises that stimulants should generally not be used in people with serious heart problems or conditions where even modest increases in heart rate or blood pressure could be dangerous. Symptoms like chest pain, shortness of breath, or fainting while on a stimulant warrant immediate medical attention.
Controlled Substance Classification
All prescription stimulants are classified as Schedule II controlled substances under the Controlled Substances Act, the same category as opioid painkillers. This reflects their potential for misuse, addiction, and diversion. In practical terms, this means prescriptions typically cannot be called in by phone in most states, refills require a new prescription, and there are limits on how much can be dispensed at once. Your prescriber will generally want to see you regularly to monitor how you’re responding and to renew the prescription.